If youve been focused on cardio, add some strength training into the mix
The network of providers used by MedVi will make all the decisions regarding what prescriptions a user receives
+ Facility Inspections FDA Warning Letters Company: Apothecary Pharma, LLC Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: December 1, 2025
Patients on tablets, drops, or tirzepatide pay more per month medication, with the membership stacked on top
doi:10.1089/dia.2014.0412 54
Compounded semaglutide GLP-1, on the other hand, offers customization but lacks the high level of regulatory oversight and consistency associated with brand-name formulations